Agents | ED50 Value (95% C.I.) | Dose Range | ||
---|---|---|---|---|
Phase II | Phase IIA | |||
nmol | ||||
Gal1-29 | 19 (8-47) | 11 (5-26) | 3-30 | |
Mor | 4 (1-11) | 2 (1-6) | 0.3-90 | |
Mor (+Gal1-29)a | 1 (1-2) | 1 (0.7-1.2) | 0.45-1.8 | |
AP-5 | 60 (34-105) | 54 (37-79) | 5.6-152 | |
AP-5 (+Gal1-29)a | 15 (10-23) | 13 (9-17) | 6.5-26 |
↵ a The combination doses were defined by ratio of the ED50 of respective drug given alone.